3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Lung Neoplasms
11
Melanoma
4
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Hematologic Neoplasms
2
Glioma
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Solid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Noonan Syndrome 5
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hereditary Sensory and Autonomic Neuropathies
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Interventions
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Noonan Syndrome 5
×
binimetinib
×
Thoracic
×
Clear all
NCT01885195
2021-02-21
SIGNATURE
Pfizer
Phase 2
Completed
110 enrolled
18 charts